This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bates, S. M.
Right arrow Articles by Sackett, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bates, S. M.
Right arrow Articles by Sackett, D. L.
Related Collections
Right arrow Screening tests
Right arrow Venous thromboembolism
Right arrow Diagnostic tests
Right arrow Laboratory Medicine - see also Molecular Medicine
Right arrow Genetics
Right arrow Hematologic pathology (including blood transfusion)
CMAJ • October 17, 2000; 163 (8)
© 2000 Canadian Medical Association or its licensors

Review
Synthèse

Criteria for evaluating evidence that laboratory abnormalities are associated with the development of venous thromboembolism

Shannon M. Bates*, Jeffrey S. Ginsberg*{dagger}, Sharon E. Straus{ddagger}, Hans Rekers§ and David L. Sackett

From *the Department of Medicine, McMaster University, Hamilton, Ont.; {dagger}Hamilton Civic Hospitals Research Centre, Hamilton, Ont.; {ddagger}the Department of Medicine, University of Toronto, Toronto, Ont.; §NV Organon, Oss, the Netherlands; and ¶the Trout Education and Research Centre, Trout Lake, Ont.

Abstract

THE IDENTIFICATION OF CONDITIONS ASSOCIATED WITH an increased risk of venous thromboembolism may indicate the need for aggressive prophylaxis during periods of high risk, prolonged anticoagulant therapy after an initial venous thromboembolic episode, the investigation of asymptomatic family members and the avoidance of oral contraceptives. Advances in laboratory medicine have led to the identification and assessment of many proteins responsible for normal hemostasis, and associations between abnormalities in a number of these proteins and venous thromboembolism have been reported. Without the ability to appraise this information critically, physicians may be unable to determine whether or how they should modify their clinical practice. Criteria for determining whether specific laboratory abnormalities have a relationship with venous thromboembolism are proposed here, and one example of the application of these guidelines is provided.




This article has been cited by other articles:


Home page
 BMJHome page
S. E Straus
Bridging the gaps in evidence based diagnosis.
BMJ, August 26, 2006; 333(7565): 405 - 406.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. J. McQueen
Overview of Evidence-based Medicine: Challenges for Evidence-based Laboratory Medicine
Clin. Chem., August 1, 2001; 47(8): 1536 - 1546.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
S. Solymoss
Risk factors for thromboembolism: pathophysiology and detection
Can. Med. Assoc. J., October 1, 2000; 163(8): 991 - 994.
[Full Text] [PDF]